Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers

NCT02871232 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 26500

Last updated 2016-08-25

No results posted yet for this study

Summary

To conduct surveillance for abuse, misuse, overdose, addiction, and death and to evaluate if the REMS meets its surveillance goals, and if it does not, to modify it appropriately based on the metrics. Briefly, therefore, the overall surveillance objective is to evaluate for trends before and after the shared REMS is implemented to collectively assess for changes in abuse, misuse, overdose, addiction, and death for different risk groups and settings.

Conditions

Interventions

OTHER

Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) System of post-marketing surveillance of prescription medication abuse, misuse, and diversion

Sponsors & Collaborators

  • ER/LA Opioid REMS Program Companies (RPC)

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2016-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02871232 on ClinicalTrials.gov